| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 20,689 | 20,197 | 18,520 | 18,957 |
| Cost of revenue (excluding amortization of intangible assets) | 6,625 | 5,997 | 5,913 | 6,004 |
| Amortization of intangible assets | 95 | 95 | 95 | 95 |
| Gross profit | 13,969 | 14,105 | 12,512 | 12,858 |
| Sales and marketing | 15,227 | 16,857 | 16,608 | 16,472 |
| General and administrative | 3,948 | 4,126 | 3,836 | 3,683 |
| Research and development | 2,348 | 2,203 | 2,540 | 2,068 |
| Total operating expenses | 21,523 | 23,186 | 22,984 | 22,223 |
| Loss from operations | -7,554 | -9,081 | -10,472 | -9,365 |
| Interest expense | 1,201 | 1,188 | 1,219 | 1,344 |
| Other income | 152 | 379 | 479 | 337 |
| Total other expense, net | -1,049 | -809 | -740 | -1,007 |
| Loss before income tax expense | -8,603 | -9,890 | -11,212 | - |
| Income tax expense | - | 33 | 52 | - |
| Net loss | -8,603 | -9,923 | -11,264 | -10,372 |
| Foreign currency translation adjustment | -2 | 2 | 1 | 51 |
| Comprehensive loss | -8,605 | -9,921 | -11,263 | -10,321 |
| Earnings per share, basic | -0.19 | -0.22 | -0.25 | -0.42 |
| Earnings per share, diluted | -0.19 | -0.22 | -0.25 | -0.42 |
| Weighted average number of shares outstanding, basic | 45,421,795 | 45,365,325 | 45,267,020 | 24,703,578 |
| Weighted average number of shares outstanding, diluted | 45,421,795 | 45,365,325 | 45,267,020 | 24,703,578 |
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)